Level Biotechnology (3118) — Financial Flexibility Index
Level Biotechnology (3118) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of NT$16.26 Million (operating CF NT$11.81 Million minus capex NT$4.44 Million) represents 0% of total liabilities (NT$237.03 Million). Check Level Biotechnology (3118) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Level Biotechnology Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Level Biotechnology across 8 annual periods. For the full cash flow conversion analysis, see Level Biotechnology cash flow conversion.
Annual Financial Flexibility Index for Level Biotechnology (2017–2024)
Year-by-year free cash flow to debt coverage for Level Biotechnology. Explore 3118 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.08x | NT$287.77 Million | NT$64.10 Million | NT$267.19 Million | ▲ +277.8% |
| 2023 | 0.29x | NT$77.88 Million | NT$70.21 Million | NT$273.20 Million | ▲ +7.2% |
| 2022 | 0.27x | NT$71.81 Million | NT$65.07 Million | NT$270.13 Million | ▼ -60.9% |
| 2021 | 0.68x | NT$165.10 Million | NT$155.95 Million | NT$242.78 Million | ▲ +93.1% |
| 2020 | 0.35x | NT$85.77 Million | NT$83.23 Million | NT$243.56 Million | ▼ -25.3% |
| 2019 | 0.47x | NT$111.45 Million | NT$109.02 Million | NT$236.43 Million | ▲ +192.3% |
| 2018 | 0.16x | NT$29.29 Million | NT$26.77 Million | NT$181.60 Million | ▼ -58.8% |
| 2017 | 0.39x | NT$82.12 Million | NT$71.29 Million | NT$210.03 Million | — |